etodolac has been researched along with Ischemia in 3 studies
Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
Excerpt | Relevance | Reference |
---|---|---|
" Here, we evaluated the influence of aspirin and etodolac, a selective cyclooxygenase-2 inhibitor, on neovascularization using a murine ischemia hind limb model." | 3.76 | The cyclooxygenase-2 selective inhibitor, etodolac, but not aspirin reduces neovascularization in a murine ischemic hind limb model. ( Hisatome, I; Kita, Y; Shimizu, T; Tanaka, K; Tsujimoto, S; Uozumi, N; Yamamoto, Y; Yoshida, A, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hirono, J | 1 |
Sanaki, H | 1 |
Kitada, K | 1 |
Sada, H | 1 |
Suzuki, A | 1 |
Lie, LK | 1 |
Segi-Nishida, E | 1 |
Nakagawa, K | 1 |
Hasegawa, H | 1 |
Tanaka, K | 1 |
Yamamoto, Y | 1 |
Tsujimoto, S | 1 |
Uozumi, N | 1 |
Kita, Y | 1 |
Yoshida, A | 1 |
Shimizu, T | 1 |
Hisatome, I | 1 |
Tomlinson, JE | 1 |
Wilder, BO | 1 |
Young, KM | 1 |
Blikslager, AT | 1 |
3 other studies available for etodolac and Ischemia
Article | Year |
---|---|
Expression of tissue inhibitor of metalloproteinases and matrix metalloproteinases in the ischemic brain of photothrombosis model mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain; Disease Models, Animal; Endothelia | 2018 |
The cyclooxygenase-2 selective inhibitor, etodolac, but not aspirin reduces neovascularization in a murine ischemic hind limb model.
Topics: Animals; Aspirin; Bone Marrow Cells; Cell Transplantation; Cyclooxygenase 1; Cyclooxygenase 2; Cyclo | 2010 |
Effects of flunixin meglumine or etodolac treatment on mucosal recovery of equine jejunum after ischemia.
Topics: Animals; Biological Transport; Blotting, Western; Clonixin; Cyclooxygenase 1; Cyclooxygenase 2; Cycl | 2004 |